News
-
-
COMMUNIQUÉ DE PRESSE
SpeedSize Implements AI-Powered Media Optimization to Deliver Fast and Engaging Online Experience for Never Fully Dressed
Never Fully Dressed partners with SpeedSize for AI-driven media optimization, enhancing website speed and user experience without compromising quality. SpeedSize's technology reduces image sizes while preserving brand's visual appeal -
-
-
COMMUNIQUÉ DE PRESSE
Formycon and Fresenius Kabi receive positive CHMP opinion for FYB202 (Ustekinumab), a biosimilar candidate to Stelara®
Formycon and Fresenius Kabi receive positive CHMP opinion for FYB202 biosimilar candidate to Stelara. Approval expected in early Q4 2024. Biosimilars boost healthcare access & reduce costs globally -
COMMUNIQUÉ DE PRESSE
Attestation personne responsable
-
COMMUNIQUÉ DE PRESSE
Rapport des CAC
-
COMMUNIQUÉ DE PRESSE
Rapport financier semestriel
-
-